Validation of a cataplexy questionnaire in 983 sleep-disorders patients.
about
Anomalous hypothalamic responses to humor in cataplexyHuman hypocretin and melanin-concentrating hormone levels are linked to emotion and social interaction.Treatment paradigms for cataplexy in narcolepsy: past, present, and futureClassification of sleep disorders.Evidence for metabolic hypothalamo-amygdala dysfunction in narcolepsy.Insufficient non-REM sleep intensity in narcolepsy-cataplexy.Laughter and MIRTH (Methodical Investigation of Risibility, Therapeutic and Harmful): narrative synthesis.Narcolepsy and orexins: an example of progress in sleep research.Depression: relationships to sleep paralysis and other sleep disturbances in a community sample.Does narcolepsy symptom severity vary according to HLA-DQB1*0602 allele status?Narcolepsy and predictors of positive MSLTs in the Wisconsin Sleep Cohort.Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population.A case of narcolepsy with strictly unilateral cataplexy.Environmental toxins and risk of narcolepsy among people with HLA DQB1*0602.Clinical and therapeutic aspects of childhood narcolepsy-cataplexy: a retrospective study of 51 children.Nocturnal rapid eye movement sleep latency for identifying patients with narcolepsy/hypocretin deficiency.Genetic association, seasonal infections and autoimmune basis of narcolepsyPresentations of primary hypersomnia in Chinese children.Complex movement disorders at disease onset in childhood narcolepsy with cataplexy.Narcolepsy and the Sickness Impact Profile: A general health status measureMedical exposures in youth and the frequency of narcolepsy with cataplexy: a population-based case-control study in genetically predisposed people.Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy.Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexyEffects of orexin gene transfer in the dorsolateral pons in orexin knockout miceChallenging sleep homeostasis in narcolepsy-cataplexy: implications for non-REM and REM sleep regulation.Prevalence of eating disorders and eating attacks in narcolepsyExploring the presence of narcolepsy in patients with schizophrenia.Narcolepsy: immunological aspects.HLA-DQB1 allele and hypocretin in Korean narcoleptics with cataplexyPrevalence of narcolepsy in King County, Washington, USA.Body mass index-independent metabolic alterations in narcolepsy with cataplexy.A patient with intractable attacks of cataplexy.Challenges in the development of therapeutics for narcolepsy.Patient-Reported Measures of Narcolepsy: The Need for Better Assessment.Running promotes wakefulness and increases cataplexy in orexin knockout mice.Normal Morning Melanin-Concentrating Hormone Levels and No Association with Rapid Eye Movement or Non-Rapid Eye Movement Sleep Parameters in Narcolepsy Type 1 and Type 2.Narcoleptic orexin receptor knockout mice express enhanced cholinergic properties in laterodorsal tegmental neuronsThe anatomical, cellular and synaptic basis of motor atonia during rapid eye movement sleep.
P2860
Q21144307-2979140F-AB8C-4E0A-898A-EB7F0FE7AE90Q24606302-C51F0B61-68F3-4C38-B6B1-358B1944E0DEQ26771634-129D1D89-FB4C-48EA-B291-DE20D2487F95Q26827155-379ACBA9-950F-4AD5-827C-A009F5BECFECQ30485748-CE89E24E-5603-4B11-8AF3-02296DFD5CF2Q30497099-222E9141-0C92-4D86-8F43-658B10FCDC48Q33163620-0FA9F1C3-FD2F-4D29-BBA3-F287CC12A9F7Q33351116-494D5B91-EB7D-4D59-B97F-5733FCA60F52Q33568432-AEE75A16-A31D-4E84-965D-0E6B8ED55807Q33573841-EE516F65-05E4-4766-8109-1D0FF0DD9515Q33587566-FB2A5F29-A328-4FC1-8ABC-C442065048BDQ33635419-DBFD6232-B433-4904-B9F1-632E16896EE7Q33660564-1E65BE40-07B9-4BE6-A3C2-5AC150C6CC92Q34092956-29240BAB-BA41-4DF2-8D9F-334782B47EAEQ34197619-39DAA811-4802-4540-B99E-441EBD6D4908Q34222793-FD84BA0C-1FA3-49D1-840C-6BDA79EFA614Q34333298-7EDC12FA-48E2-4840-A251-32D374CE0869Q34821484-15FB89DC-589C-4055-ABF7-31525283DE4DQ35606698-7F8F72F9-921C-4DA9-941D-6BC126B874BDQ35907137-B6386E70-D3FD-4FCC-B720-E43712E9D7B0Q35936309-69801A52-9F6E-4F0B-9A81-2C2CBD38AF15Q36143066-94627057-C635-4762-AD2D-5013873004E0Q36147074-22574DCE-D5B0-4570-8E82-973A0361BF69Q36473239-B23CED1A-D377-4E45-8A9C-FF97B9DBF265Q36741809-4F4E1F41-1C05-4096-BA76-A5BE393A6038Q36836807-DC37FD86-C28F-4791-BAAE-C70B1B90477FQ36955561-EBCD8FBB-F933-442B-B23E-402BC5BC0F99Q37091394-886CA360-D420-4650-AEC9-653E82E83C16Q37220187-7B67DA19-369A-46E7-A80C-50D599E5290FQ37368887-1AEA3F9E-0B43-4448-9FEC-325DA52C64CAQ37402576-AD98E975-FA2A-4F27-A0B4-EC7ECBF872B1Q38152734-99222301-3823-4D87-A79F-C6CB099754B8Q38684472-6F732E91-A17A-4A9E-A16D-FD90FDEBD68DQ39120212-DC8BC146-3603-44E2-B8E2-25988128C8EBQ40243643-7258EFCD-F165-45F5-8220-CEAC92303F0AQ42124350-F68AD11F-39A9-441B-99CA-946EB003FBC8Q42419076-A57AB1C1-0A21-449A-A5F8-6CE6FA27A302Q47869796-6861688D-D9FF-4E15-B425-EE59878A9D66
P2860
Validation of a cataplexy questionnaire in 983 sleep-disorders patients.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Validation of a cataplexy questionnaire in 983 sleep-disorders patients.
@en
type
label
Validation of a cataplexy questionnaire in 983 sleep-disorders patients.
@en
prefLabel
Validation of a cataplexy questionnaire in 983 sleep-disorders patients.
@en
P2093
P1433
P1476
Validation of a cataplexy questionnaire in 983 sleep-disorders patients.
@en
P2093
Anic-Labat S
Arrigoni J
Guilleminault C
Kraemer HC
P577
1999-02-01T00:00:00Z